Authors:
Greenbaum, AB
Harrington, RA
Hudson, MP
MacAulay, CM
Wilcox, RG
Simoons, ML
Berdan, LG
Guerci, A
Cokkinos, DV
Kitt, MM
Lincoff, AM
Topol, EJ
Califf, RM
Ohman, EM
Citation: Ab. Greenbaum et al., Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 492-498
Citation: A. Guerci et al., Aneugenic effects of some metal compounds assessed by chromosome counting in MRC-5 human cells, MUT RES-GTE, 469(1), 2000, pp. 35-40
Authors:
Mouron, SA
Abba, MC
Guerci, A
Gomez, MA
Dulout, FN
Golijow, CD
Citation: Sa. Mouron et al., Association between activated K-ras and c-erbB-2 oncogenes with ''high-risk'' and ''low-risk'' Human Papilloma Virus types in preinvasive cervical lesions, MUT RES-GTE, 469(1), 2000, pp. 127-134
Authors:
Fenaux, P
Chevret, S
Guerci, A
Fegueux, N
Dombret, H
Thomas, X
Sanz, M
Link, H
Maloisel, F
Gardin, C
Bordessoule, D
Stoppa, AM
Sadoun, A
Muus, P
Wandt, H
Mineur, P
Whittaker, JA
Fey, M
Daniel, MT
Castaigne, S
Degos, L
Citation: P. Fenaux et al., Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1371-1377
Authors:
Thomas, X
Dombret, H
Cordonnier, C
Pigneux, A
Gardin, C
Guerci, A
Vekhoff, A
Sadoun, A
Stamatoullas, A
Fegueux, N
Maloisel, F
Cahn, JY
Reman, O
Gratecos, N
Berthou, C
Huguet, F
Kotoucek, P
Travade, P
Buzyn, A
de Revel, T
Vilque, JP
Naccache, P
Chomienne, C
Degos, L
Fenaux, P
Citation: X. Thomas et al., Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation, LEUKEMIA, 14(6), 2000, pp. 1006-1013
Authors:
de Botton, S
Chevret, S
Sanz, M
Dombret, H
Thomas, X
Guerci, A
Fey, M
Rayon, C
Huguet, F
Sotto, JJ
Gardin, C
Makhoul, PC
Travade, P
Solary, E
Fegueux, N
Bordessoule, D
San Miguel, J
Link, H
Desablens, B
Stamatoullas, A
Deconinck, E
Geiser, K
Hess, U
Maloisel, F
Castaigne, S
Preudhomme, C
Chomienne, C
Degos, L
Fenaux, P
Citation: S. De Botton et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, BR J HAEM, 111(3), 2000, pp. 801-806
Authors:
Wattel, E
Solary, E
Leleu, X
Dreyfus, F
Brion, A
Jouet, JP
Hoang-Ngoc, L
Maloisel, F
Guerci, A
Rochant, H
Gratecos, N
Casassus, P
Janvier, M
Brice, P
Lepelley, P
Fenaux, P
Citation: E. Wattel et al., A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes, LEUKEMIA, 13(4), 1999, pp. 524-529
Authors:
Alexander, JH
Harrington, RA
Tuttle, RH
Berdan, LG
Lincoff, AM
Deckers, JW
Simoons, ML
Guerci, A
Hochman, JS
Wilcox, RG
Kitt, MM
Eisenberg, PR
Califf, RM
Topol, EJ
Karsh, K
Ruzyllo, W
Stepinska, J
Widimsky, P
Boland, JB
Armstrong, PW
Citation: Jh. Alexander et al., Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes, AM J CARD, 83(8), 1999, pp. 1147-1151
Authors:
Alexander, KP
Peterson, ED
Granger, CB
Casas, AC
Van de Werf, F
Armstrong, PW
Guerci, A
Topol, EJ
Califf, RM
Citation: Kp. Alexander et al., Potential impact of evidence-based medicine in acute coronary syndromes: Insights from GUSTO-IIb, J AM COL C, 32(7), 1998, pp. 2023-2030